BHV-8000, a Selective Brain-penetrant TYK2/JAK1 Inhibitor in Development for Neuroinflammatory and Neurodegenerative Diseases, Demonstrates Efficacy in an Alpha-Synuclein Overexpressing Parkinson’s Disease Mouse Model (S4.006)
Year: 2025
Type: article
Source: Neurology
Authors: Chris Liang, Wei Tang, Bavani Shankar, Bruce Car, Irfan Qureshi, Vlad Coric, Lindsey Lair
Institution: Biohaven Pharmaceuticals (United States)
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409228433